Developing physiologically-based toxicokinetic (PBTK) models to - - PowerPoint PPT Presentation

developing physiologically based toxicokinetic pbtk
SMART_READER_LITE
LIVE PREVIEW

Developing physiologically-based toxicokinetic (PBTK) models to - - PowerPoint PPT Presentation

Developing physiologically-based toxicokinetic (PBTK) models to assess occupational exposure to haloxyfop- methyl ester. PHE/ ICL Alex Cooper Intro to PBTK modelling & aims Results Further work --/--/2017 PBTK modelling


slide-1
SLIDE 1
  • -/--/2017

PHE/ ICL Alex Cooper Developing physiologically-based toxicokinetic (PBTK) models to assess occupational exposure to haloxyfop- methyl ester.

  • Intro to PBTK modelling & aims
  • Results
  • Further work
slide-2
SLIDE 2

PBTK modelling

slide-3
SLIDE 3

Construct rodent PBTK models for herbicides Calibrate models with rodent toxicokinetic data Exposure reconstruction with human biomonitoring data Extrapolate models to humans

Calibrate parameters common to both species Calibrate human- specific parameters Calibrate mouse- specific parameters Mouse toxicokinetic data Human toxicokinetic data Human biomonitoring data

Exposure reconstruction

Project overview

slide-4
SLIDE 4

Hypothesis & aims

Hypothesis: PBTK models can be calibrated and used to accurately calculate tissue exposures for use in risk assessment.

  • To reconstruct human external exposure, using a calibrated human

PBTK model and human biomonitoring data. Aims:

  • To investigate if there are different biologically-plausible approaches to

fitting toxicokinetic data in the same rodent PBTK model, and once extrapolated to humans, whether these have different implications for internal exposure assessment.

  • To infer exposure in target tissues of interest using a calibrated

human PBTK model.

slide-5
SLIDE 5

Acceptable Operator Exposure Limit (AOEL) is 0.005 mg/ Kg/ day

  • AOEL is ‘the maximum internal (absorbed) amount of active substance to which operator

may be exposed (from all absorption routes) without adverse health effects’ (European Commission)

  • expressed as internal levels (mg/ kg bw/ day)

Inhibits ACCase liver toxicity (NOAEL is 0.5 mg/ Kg bw/ day) ÷ 100 peroxisome proliferation

Case study: haloxyfop-methyl ester

slide-6
SLIDE 6

Octanol: water partition coefficient (logPo:w) for haloxyfop-P

  • assay performed to provide additional biochemical data for

model calibration

  • performed as described in OECD (1995), and modified to

resemble physiological conditions (37 °C, using PBS pH 7.4 for aqueous layer).

  • No significant difference between both experimental conditions

(p = 0.85,α = 0.05; n = 10).

  • QSAR value is 3.93!
slide-7
SLIDE 7
slide-8
SLIDE 8
slide-9
SLIDE 9

PPARα receptor binding Model liver transporter activity (NO PPARα receptor binding) Fit liver toxicokinetic data

slide-10
SLIDE 10

Extrapolate from mouse (with PPARα receptor binding) Extrapolate from mouse (with liver transporter activity)

Maximum tissue exposure (individual C) Concentration (ng/ g-tissue)

slide-11
SLIDE 11

Extrapolate from mouse (with PPARα receptor binding) Extrapolate from mouse (with liver transporter activity)

Risk assessment: Operator maximum systemic exposure

UK-POEM model German model

AOEL

Dose (mg/ Kg bw) Dose (mg/ Kg bw)

A B C A B C

slide-12
SLIDE 12

Take home message

PBTK models can be calibrated and used to accurately calculate tissue exposures for use in risk assessment

slide-13
SLIDE 13

Further work

  • Determine concentration ratio between human

blood & plasma

  • Fraction unbound in human plasma
  • Partition coefficient between veg. oil & water
  • Assess exposure to brominated flame retardants
slide-14
SLIDE 14

Thanks

www.nihr.ac.uk

Tim Ebbels Manoj Aggarwal Michael Bartels Claire Terry Tina Mehta Matt Puncher Gwyn Lord Tim Gant